Anticancer agent 136 (compound 22), a C17-triazole analogue of Geldanamycin (GDM, HY-15230), has an IC50 of 3.38 µM for HDF and a Kd of 3.86 µM for Hsp90. Anticancer agent 136 is an apoptosis-inducing agent[1].
Molecular Weight:
742.86
Formula:
C40H50N6O8
Target:
Apoptosis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
